1. Home
  2. CGTX vs DTSS Comparison

CGTX vs DTSS Comparison

Compare CGTX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • DTSS
  • Stock Information
  • Founded
  • CGTX 2007
  • DTSS 2014
  • Country
  • CGTX United States
  • DTSS China
  • Employees
  • CGTX N/A
  • DTSS N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • CGTX Health Care
  • DTSS Technology
  • Exchange
  • CGTX Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • CGTX 20.5M
  • DTSS 16.5M
  • IPO Year
  • CGTX 2021
  • DTSS N/A
  • Fundamental
  • Price
  • CGTX $0.26
  • DTSS $2.03
  • Analyst Decision
  • CGTX Strong Buy
  • DTSS
  • Analyst Count
  • CGTX 5
  • DTSS 0
  • Target Price
  • CGTX $5.63
  • DTSS N/A
  • AVG Volume (30 Days)
  • CGTX 1.8M
  • DTSS 94.2K
  • Earning Date
  • CGTX 08-07-2025
  • DTSS 05-14-2025
  • Dividend Yield
  • CGTX N/A
  • DTSS N/A
  • EPS Growth
  • CGTX N/A
  • DTSS N/A
  • EPS
  • CGTX N/A
  • DTSS N/A
  • Revenue
  • CGTX N/A
  • DTSS $56,255,129.00
  • Revenue This Year
  • CGTX N/A
  • DTSS N/A
  • Revenue Next Year
  • CGTX N/A
  • DTSS N/A
  • P/E Ratio
  • CGTX N/A
  • DTSS N/A
  • Revenue Growth
  • CGTX N/A
  • DTSS 144.20
  • 52 Week Low
  • CGTX $0.22
  • DTSS $1.63
  • 52 Week High
  • CGTX $2.54
  • DTSS $7.67
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 37.68
  • DTSS 41.07
  • Support Level
  • CGTX $0.29
  • DTSS $2.10
  • Resistance Level
  • CGTX $0.32
  • DTSS $2.18
  • Average True Range (ATR)
  • CGTX 0.03
  • DTSS 0.14
  • MACD
  • CGTX 0.00
  • DTSS -0.03
  • Stochastic Oscillator
  • CGTX 12.50
  • DTSS 4.65

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: